Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Lowered by Wall Street Zen

Guardian Pharmacy Services (NYSE:GRDN) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday, Wall Street Zen reports.

Other analysts have also issued research reports about the stock. Oppenheimer lifted their target price on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, August 20th. Truist Financial raised their price target on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Finally, Bank of America lifted their price objective on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $43.83.

Guardian Pharmacy Services Price Performance

Shares of GRDN stock opened at $45.02 on Friday. The company has a market cap of $2.24 billion, a price-to-earnings ratio of 43.71, a PEG ratio of 2.33 and a beta of 0.06. The stock has a 50 day simple moving average of $40.48 and a 200-day simple moving average of $38.92. Guardian Pharmacy Services has a 1-year low of $23.14 and a 1-year high of $48.33.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. The firm had revenue of $351.77 million for the quarter, compared to analysts’ expectations of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. Analysts anticipate that Guardian Pharmacy Services will post 1.19 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of hedge funds have recently modified their holdings of the business. First Trust Advisors LP purchased a new stake in Guardian Pharmacy Services during the 1st quarter valued at about $3,528,000. Dimensional Fund Advisors LP raised its holdings in Guardian Pharmacy Services by 200.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock valued at $7,855,000 after acquiring an additional 139,070 shares during the last quarter. Bank of America Corp DE lifted its stake in Guardian Pharmacy Services by 86.1% in the 1st quarter. Bank of America Corp DE now owns 128,048 shares of the company’s stock worth $4,822,000 after purchasing an additional 59,245 shares in the last quarter. Sanctuary Advisors LLC purchased a new position in Guardian Pharmacy Services in the 1st quarter worth approximately $1,352,000. Finally, Globeflex Capital L P acquired a new position in shares of Guardian Pharmacy Services during the 4th quarter worth approximately $1,335,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.